Literature DB >> 7955302

The clinical management of keratoconus: a 6 year retrospective study.

M J Crews1, W T Driebe, G A Stern.   

Abstract

We conducted a retrospective analysis of the management of 118 eyes of 66 new patients presenting with keratoconus at the University of Florida from 1987 through 1992. Eyes were ultimately managed by one of three methods: glasses or no correction; contact lenses; or penetrating keratoplasty. The outcome of each management method was determined by evaluating initial and final vision and keratometry for each group. Twenty-one eyes received glasses or required no correction. Rigid gas permeable lenses, Dura-T style PMMA lenses, and specialty design gas permeable lenses were used to successfully fit 63 eyes. Twenty-eight eyes underwent penetrating keratoplasty (PK), and an additional six eyes were PK candidates. Factors associated with the need for PK included best corrected initial visual acuity of 20/40 or worse, average keratometry > 55 D, and the presence of apical scarring (P < 0.001).

Entities:  

Mesh:

Year:  1994        PMID: 7955302     DOI: 10.1097/00140068-199407000-00013

Source DB:  PubMed          Journal:  CLAO J        ISSN: 0733-8902


  10 in total

1.  Contrast and glare testing in keratoconus and after penetrating keratoplasty.

Authors:  K Pesudovs; P Schoneveld; R J Seto; D J Coster
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

2.  A genome-wide association study identifies a potential novel gene locus for keratoconus, one of the commonest causes for corneal transplantation in developed countries.

Authors:  Xiaohui Li; Yelena Bykhovskaya; Talin Haritunians; David Siscovick; Anthony Aldave; Loretta Szczotka-Flynn; Sudha K Iyengar; Jerome I Rotter; Kent D Taylor; Yaron S Rabinowitz
Journal:  Hum Mol Genet       Date:  2011-10-06       Impact factor: 6.150

3.  Influence of intrastromal corneal ring segment implantation on corneal biomechanical parameters in keratoconic eyes.

Authors:  Ebru Gorgun; Raciha Beril Kucumen; Nursal Melda Yenerel
Journal:  Jpn J Ophthalmol       Date:  2011-07-16       Impact factor: 2.447

4.  The lifetime economic burden of keratoconus: a decision analysis using a markov model.

Authors:  Ronald L Rebenitsch; Steven M Kymes; Jeffrey J Walline; Mae O Gordon
Journal:  Am J Ophthalmol       Date:  2011-02-18       Impact factor: 5.258

Review 5.  The genetic and environmental factors for keratoconus.

Authors:  Ariela Gordon-Shaag; Michel Millodot; Einat Shneor; Yutao Liu
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

6.  Characteristics of Keratoconic Patients Attending a Specialist Contact Lens Clinic in Kenya.

Authors:  Zahra Aly Rashid; Michel Millodot; Katharine S E Evans
Journal:  Middle East Afr J Ophthalmol       Date:  2016 Oct-Dec

7.  Results in keratoconus correction with Kerasoft 3 Contact lenses.

Authors:  Cristina Nicula; Dorin Nicula; Corina Suciu
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

Review 8.  Genetic Aspects of Keratoconus: A Literature Review Exploring Potential Genetic Contributions and Possible Genetic Relationships with Comorbidities.

Authors:  Eleftherios Loukovitis; Konstantinos Sfakianakis; Panagiota Syrmakesi; Eleni Tsotridou; Myrsini Orfanidou; Dimitra Rafailia Bakaloudi; Maria Stoila; Athina Kozei; Spyridon Koronis; Zachos Zachariadis; Paris Tranos; Nikos Kozeis; Miltos Balidis; Zisis Gatzioufas; Aliki Fiska; George Anogeianakis
Journal:  Ophthalmol Ther       Date:  2018-09-06

9.  Changes in Corneal Morphology with Age in Asian Population: A Multicenter Study of 30,618 Cases.

Authors:  Ruijue Ma; Yuanyuan Liu; Lin Zhang; Jiaonan Ma; Tong Cui; Yulin Lei; Jie Hou; Zhengwei Shen; Xianglong Yi; Gang Liang; Yan Wang
Journal:  Adv Ther       Date:  2021-10-10       Impact factor: 3.845

10.  Lack of association between polymorphisms of the DNA base excision repair genes MUTYH and hOGG1 and keratoconus in a Polish subpopulation.

Authors:  Ewelina Synowiec; Katarzyna A Wójcik; Anna Czubatka; Piotr Polakowski; Justyna Izdebska; Jerzy Szaflik; Janusz Błasiak; Jacek P Szaflik
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.